SCHEMBL3565974

SCHEMBL3565974

CCOC(=O)C1=C(c2ccccc2)c2ccc(CN3CCOCC3)cc2C1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 11/20 0.59
ALDH1A1 P00352 5/20 0.52
PDCD1 Q15116 1/20 0.50
CD274 Q9NZQ7 1/20 0.50
TSHR P16473 4/20 0.46
LMNA P02545 3/20 0.46
MAPT P10636 3/20 0.46
MAPK1 P28482 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
STAT3 P40763 1/20 0.46
NPSR1 Q6W5P4 3/20 0.46
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
HSP90AA1 P07900 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4658819 0.95 PPARG (0.54) PPARGALDH1A1PDCD1CD274TSHR
SCHEMBL4657478 0.88 PPARG (0.47) PPARGALDH1A1PDCD1CD274TSHR
SCHEMBL13316128 0.87 PPARG (0.74) PPARG
SCHEMBL3572873 0.83 PPARG (0.79) PPARGRAB9ANPC1
SCHEMBL3572958 0.80 PPARG (0.69) PPARGALDH1A1LMNAMAPTMAPK1
SCHEMBL3576647 0.77 PPARG (0.76) PPARGALDH1A1LMNAMAPTMAPK1
SCHEMBL3578413 0.77 ALDH1A1 (0.48) PPARGALDH1A1PDCD1CD274TSHR
SCHEMBL4658204 0.76 PPARG (0.64) PPARGALDH1A1LMNAMAPTMAPK1
SCHEMBL3570952 0.76 PPARG (0.74) PPARGALDH1A1LMNAMAPTMAPK1
SCHEMBL7538581 0.76 PPARG (0.72) PPARGALDH1A1LMNAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745439-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-29 US disclosed
US-7741323-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-22 US disclosed
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof JEIL PHARM. CO., LTD. (KR) 2007-09-27 US disclosed
US-20070185109-A1 Idene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2007-08-09 US disclosed
EP-1740531-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Korea Research Institute of Chemical Technology (KR) 2007-01-10 EP disclosed
WO-2005100303-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185109-A1 Idene derivatives and process for the preparation thereof INSR, PPARD, GPR119 PPARG 5/4885ALDH1A1 940/4885PDCD1 3359/4885
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof INSR, GPR119, PPARA PPARG 8/4885ALDH1A1 773/4885PDCD1 2017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.